Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Isotope & RadiationHKSE:01763 -1.88%92 OCF Yield % is 11.19 as of Aug. 27, 2026, which is 12% above its 10-year median of 9.97. GuruFocus rates HKSE:01763 with a GF Score™ of 92/100 and a GF Value™ of HK$15.74 (Fairly Valued). The stock has 5 warning signs investors should review. Among 850 Medical Devices & Instruments companies, China Isotope & Radiation ranks better than 89.41% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for China Isotope & Radiation's OCF Yield % or its related term are showing as below:
HKSE:01763'
s OCF Yield % Range Over the Past 10 Years
Min: 2.03 Med: 9.97 Max: 24.78
Current: 11.19
During the past 11 years, the highest OCF Yield % of China Isotope & Radiation was 24.78%. The lowest was 2.03%. And the median was 9.97%.
HKSE:01763's OCF Yield % is ranked better than 89.41% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 1.84
vs HKSE:01763: 11.19
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
China Isotope & Radiation OCF Yield % Related Terms
China Isotope & Radiation OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01763 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, China Isotope & Radiation's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's OCF Yield % distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Isotope & Radiation (HKSE:01763) has a OCF Yield % of 11.19 as of Aug. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China Isotope & Radiation and its competitors. This is 12% above median its historical median of 9.97. Over the past decade, China Isotope & Radiation's OCF Yield % has ranged from 2.03 to 24.78. According to the industry distribution chart, China Isotope & Radiation ranks #90 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 10.6%.
Is China Isotope & Radiation's OCF Yield % too high?
China Isotope & Radiation's current OCF Yield % of 11.19 is 12% above median its 10-year median of 9.97. Over the past 10 years, this metric has ranged from a low of 2.03 to a high of 24.78. The Medical Devices & Instruments industry median OCF Yield % is 1.84. China Isotope & Radiation's value of 11.19 is 508.2% above this industry median. Based on the distribution chart, China Isotope & Radiation ranks #90 out of 850 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, China Isotope & Radiation has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, China Isotope & Radiation ranks #90 out of 850 companies for OCF Yield %. This places China Isotope & Radiation in the top 11% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.84. China Isotope & Radiation's value of 11.19 is 508.2% above this benchmark. Historically, China Isotope & Radiation's own OCF Yield % has ranged from 2.03 to 24.78 over the past decade. While the company's 10-year median is 9.97 vs. the industry median of 1.84, China Isotope & Radiation has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.84, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Isotope & Radiation's current OCF Yield % of 11.19 is 508.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China Isotope & Radiation and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Isotope & Radiation's current OCF Yield % is 11.19, which is 12% above median its own 10-year median of 9.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
Based on GuruFocus' analysis, China Isotope & Radiation (HKSE:01763) is currently considered Fairly Valued. The stock's GF Value™ is HK$15.74, compared to a current price of HK$16.70 — trading 6.1% above its estimated fair value. The current OCF Yield % is 11.19, which is 12% above median its 10-year median of 9.97 and 508.2% above the Medical Devices & Instruments industry median of 1.84. China Isotope & Radiation's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For China Isotope & Radiation (HKSE:01763), the current OCF Yield % is 11.19 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Isotope & Radiation (HKSE:01763) Overvalued in 2026?
Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be overvalued.
The current stock price of HK$16.70 is trading 6.1% above its estimated GF Value™ of HK$15.74.
GuruFocus considers China Isotope & Radiation to be Fairly Valued.
Key valuation signals for HKSE:01763:
OCF Yield %: 11.19 (12% above median its 10-year median of 9.97)
GF Value™: HK$15.74 vs. price of HK$16.70 (6.1% above fair value)
Industry Position: 508.2% above the Medical Devices & Instruments median (#90 of 850)
No single metric tells the full story. See the HKSE:01763 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
92GF Score
Get the complete analysis for HKSE:01763
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01763 has been successfully added to your 
